Yahoo
NYSE - Delayed Quote USD

Ardent Health, Inc. (ARDT)

12.03 -0.27 (-2.20%)
At close: October 30 at 4:00:02 PM EDT
12.03 0.00 (0.00%)
After hours: October 30 at 4:01:23 PM EDT
Trade ARDT on Coinbase
Chart Range Bar
Loading chart for ARDT
  • Previous Close 12.30
  • Open 12.43
  • Bid 10.00 x 50000
  • Ask 13.38 x 30000
  • Day's Range 11.96 - 12.37
  • 52 Week Range 7.71 - 14.99
  • Volume 380,271
  • Avg. Volume 431,307
  • Market Cap (intraday) 1.697B
  • Beta (5Y Monthly) 0.72
  • PE Ratio (TTM) 22.28
  • EPS (TTM) 0.54
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 12.67
  • Motley Fool Rating Bearish

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

www.ardenthealth.com

19,500

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ARDT
36.24%
S&P 500 (^GSPC)
10.73%

1-Year Return

ARDT
17.49%
S&P 500 (^GSPC)
11.11%

3-Year Return

ARDT
19.80%
S&P 500 (^GSPC)
81.91%

5-Year Return

ARDT
19.80%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.62B
Earnings 16.9M
Profit Margin 1.04%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
500M
1B
2B
-1.0%
0.0%
1.0%
2.0%

Analyst Insights

View More

Analyst Price Targets

10.50 Low
12.67 Average
12.03 Current
14.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/23/2026
Analyst BMO Capital
Rating Action Initiated
Rating Market Perform
Price Action Announces
Price Target 11

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.22%

  • Return on Assets (ttm)

    3.13%

  • Return on Equity (ttm)

    9.96%

  • Revenue (ttm)

    6.41B

  • Net Income Avi to Common (ttm)

    78.23M

  • Diluted EPS (ttm)

    0.54

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    724.48M

  • Total Debt/Equity (mrq)

    130.19%

  • Levered Free Cash Flow (ttm)

    208.31M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: